Evexias BPC-157 LPT

Evexias BPC-157 LPT (body protection compound), is an endogenous, stable pentadecapeptide – 15 amino acids – first derived from gastric juices. In laboratory studies, synthetic BPC-157 is reported to:

• Support the healing of wounds, and certain injuries
• Promote recovery after tissue traumas
• Limit the impact of systemic insults including hyperkalemia and hypermagnesia

Promisingly, few studies are reporting any adverse reactions to the administration of BPC 157. BPC-157 is known to be poorly bioavailable orally; however, through this effective Evexias BPC-157 LPT liposomal tablet, bioavailability and efficacy a restored.